DYNDF yields 0.48% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, DYNDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DYNDF + JNJ for your $10,000?
Dye & Durham Limited, through its subsidiary, Dye & Durham Corporation, provides cloud-based software and technology solutions for legal firms, financial service institutions, and government organizations in Canada, Australia, Ireland, and the United Kingdom. It offers real estate and legal practice management software enabling customers to execute transactions reliably, securely, and easily; unity, a real-estate conveyancing software; and cloud-based software solutions, including online property and business regulatory information, practice management software, conveyancing workflow, electronic contracts, and legal support services. The company also provides technology-enabled real estate due diligence solutions; company formation and search services; workflow software and data insights; and white-label payment infrastructure to process online bill and tax payments. In addition, it provides due diligence searches, which are an essential component of mergers and acquisitions, and financing and restructuring transactions, as well as the process of transferring ownership in real property, mortgaging real property, and registering claims and liens against real property. The company was founded in 1874 and is headquartered in Toronto, Canada.
Full DYNDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.